Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Uipath Inc. Revenue & Financial Statements
Uipath Inc. reported revenue of $1.6B for the fiscal year ended January 31, 2026, up 12.7% year over year, with net income of $282.3M and diluted EPS of $0.52.
- Company
- Uipath Inc. PATH · NYSE
- Latest fiscal year
- FY ended Jan 31, 2026
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 892.3M | 1.1B | 1.3B | 1.4B | 1.6B |
| Cost of revenue | 168.9M | 180.1M | 195.9M | 246.9M | 271.0M |
| Gross profit | 723.4M | 878.5M | 1.1B | 1.2B | 1.3B |
| Operating income | (500.9M) | (348.3M) | (164.7M) | (162.6M) | 56.8M |
| Pretax income | (306.8M) | (273.5M) | (168.6M) | (136.5M) | (28.7M) |
| Net income | (525.6M) | (328.4M) | (89.9M) | (73.7M) | 282.3M |
| Diluted EPS | -1.16 | -0.60 | -0.16 | -0.13 | 0.52 |
| EBITDA | (494.1M) | (339.7M) | (153.6M) | (154.5M) | 73.7M |
Quarterly
| USD | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 287.3M | 325.9M | 335.1M | 316.3M | 354.7M | 356.6M | 361.7M | 411.1M |
| Cost of revenue | 49.0M | 49.9M | 55.3M | 63.3M | 63.8M | 63.9M | 64.4M | 68.8M |
| Gross profit | 238.3M | 276.0M | 279.8M | 252.9M | 290.9M | 292.8M | 297.3M | 342.3M |
| Operating income | (77.6M) | (55.8M) | (49.5M) | (103.3M) | (43.4M) | (16.4M) | (20.2M) | 13.1M |
| Pretax income | (56.5M) | (27.6M) | (25.0M) | (82.3M) | (25.5M) | (19.7M) | 3.3M | 24.6M |
| Net income | (60.4M) | (31.5M) | (28.7M) | (86.1M) | (10.7M) | (22.6M) | 1.6M | 198.8M |
| Diluted EPS | -0.11 | -0.06 | -0.05 | -0.15 | -0.02 | -0.04 | 0.00 | 0.37 |
| EBITDA | (74.8M) | (53.1M) | (47.2M) | (101.0M) | (41.3M) | (15.1M) | (19.0M) | 14.6M |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Total assets | 2.6B | 2.7B | 3.0B | 2.9B | 3.2B |
| Current assets | 2.3B | 2.3B | 2.6B | 2.3B | 2.2B |
| Cash & equivalents | 1.8B | 1.4B | 1.1B | 879.2M | 871.2M |
| Total liabilities | 650.5M | 815.0M | 938.6M | 1.0B | 1.1B |
| Current liabilities | 527.5M | 626.5M | 711.7M | 798.9M | 905.4M |
| Long-term debt | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Stockholders’ equity | 1.9B | 1.9B | 2.0B | 1.8B | 2.1B |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Operating cash flow | (55.0M) | (10.0M) | 299.1M | 320.6M | 371.2M |
| Investing cash flow | (35.4M) | (289.1M) | (439.6M) | (45.5M) | (22.5M) |
| Financing cash flow | 1.5B | (60.7M) | (196.9M) | (450.5M) | (372.4M) |
| Capital expenditure | 8.9M | 23.8M | 7.3M | 14.9M | 19.0M |
| Free cash flow | (63.8M) | (33.8M) | 291.7M | 305.6M | 352.2M |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 515.6M | 369.8M | 372.0M | 358.2M | 290.7M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every PATH filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.